SubsidieMeestersAntibacterial wound dressing based on advanced nanotechnology to improve the efficiency of wound care
Nanordica aims to revolutionize wound care with an advanced antibacterial dressing that significantly reduces infections, lowers healthcare costs, and improves patient outcomes.
Projectdetails
Introduction
Infected wounds are a major cause of limb amputations among patients with chronic diseases like diabetes. 10 million amputations occur annually, causing 100 billion additional healthcare costs. During the COVID-19 pandemic, the number of amputations rose tenfold due to the low efficacy of current solutions.
Product Development
Nanordica develops an advanced Antibacterial Wound Dressing (AWD) to prevent and treat wound infections. We have demonstrated that our AWD removes bacterial infection 8 times better than the current best solutions. Our value propositions are high efficacy and low cost.
Market Overview
The global antibacterial wound dressing market is projected to reach 4.2 billion in 2026 at a CAGR of 5.7%. Our business model is B2B, using distributors to reach our customers, i.e., hospitals.
Intellectual Property and Clinical Trials
We have a priority for intellectual property and have initiated a pilot clinical trial at the largest Estonian hospital.
Mission Statement
Our mission is to bring AWD to the market to improve the outcome of wound infections, lower healthcare costs, and help hundreds of millions of patients.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.402.750 |
| Totale projectbegroting | € 3.432.500 |
Tijdlijn
| Startdatum | 1-4-2023 |
| Einddatum | 31-3-2026 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- NANORDICA MEDICAL OUpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Medical nanofiber technology to prevent cerebrospinal leakage in neurosurgeriesNurami's ArtiFix is a revolutionary bio-absorbable patch designed to prevent cerebrospinal fluid leaks post-surgery, improving patient outcomes and reducing healthcare costs. | EIC Accelerator | € 2.495.624 | 2024 | Details |
Minimally invasive suturing for vascular bore closure and heart defect repairNovelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Novel highly sensitive NanoWire sensors for disease biomarker analysisAligned Bio's project aims to achieve TRL9 by developing a cost-effective method for mass-producing high-quality nanowire sensors, enhancing biomarker detection sensitivity by 20 times. | EIC Accelerator | € 2.315.943 | 2022 | Details |
Medical nanofiber technology to prevent cerebrospinal leakage in neurosurgeries
Nurami's ArtiFix is a revolutionary bio-absorbable patch designed to prevent cerebrospinal fluid leaks post-surgery, improving patient outcomes and reducing healthcare costs.
Minimally invasive suturing for vascular bore closure and heart defect repair
Novelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures.
Novel highly sensitive NanoWire sensors for disease biomarker analysis
Aligned Bio's project aims to achieve TRL9 by developing a cost-effective method for mass-producing high-quality nanowire sensors, enhancing biomarker detection sensitivity by 20 times.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Nanoengineered photoactivated drug-free antimicrobial precision treatment for chronic skin woundsThis project aims to validate a drug-free PHOTOCURE wound patch that uses photocatalytic activity to effectively eradicate antibiotic-resistant biofilms in chronic skin infections like diabetic foot ulcers. | ERC Proof of... | € 150.000 | 2024 | Details |
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic NeomaterialsWOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life. | EIC Pathfinder | € 2.934.318 | 2023 | Details |
Personalised Bioelectronics for Epithelial RepairProBER aims to develop personalized bioelectronic wound dressings using conformal DC electrodes to enhance healing speed and efficiency in chronic wounds, preparing for clinical studies. | ERC Proof of... | € 150.000 | 2023 | Details |
NXGHet NXG-project ontwikkelt een gebruiksvriendelijk, contactloos systeem voor efficiënte wondmonitoring, waardoor patiënten meer regie krijgen en zorgkosten verlaagd worden. | Mkb-innovati... | € 116.419 | 2017 | Details |
Antimicrobiële coating voor orthopedische trauma materialenZorgZorg Innovaties Nederland ontwikkelt een antimicrobiële Bioprex-coating voor orthopedische trauma materialen om ziekenhuisinfecties te verminderen en de marktpotentie te vergroten. | Mkb-innovati... | € 19.968 | 2022 | Details |
Nanoengineered photoactivated drug-free antimicrobial precision treatment for chronic skin wounds
This project aims to validate a drug-free PHOTOCURE wound patch that uses photocatalytic activity to effectively eradicate antibiotic-resistant biofilms in chronic skin infections like diabetic foot ulcers.
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterials
WOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life.
Personalised Bioelectronics for Epithelial Repair
ProBER aims to develop personalized bioelectronic wound dressings using conformal DC electrodes to enhance healing speed and efficiency in chronic wounds, preparing for clinical studies.
NXG
Het NXG-project ontwikkelt een gebruiksvriendelijk, contactloos systeem voor efficiënte wondmonitoring, waardoor patiënten meer regie krijgen en zorgkosten verlaagd worden.
Antimicrobiële coating voor orthopedische trauma materialen
ZorgZorg Innovaties Nederland ontwikkelt een antimicrobiële Bioprex-coating voor orthopedische trauma materialen om ziekenhuisinfecties te verminderen en de marktpotentie te vergroten.